iShares iBoxx $ Investment Grade Corporate Bond ETFLQDNYSEARCA

Loading chart...

110.17-111.13

52-Week Range103-113

103.45Current 110.87112.93

Want to monitor LQD?

Get notified when price crosses targets, volume spikes, or RSI hits oversold

No description available.

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance

Alerts

Quick Start

Key Statistics

Volume Distribution

About

News

OutRun™ | Tillage from AGCO's PTx Trimble™ Brand Wins 2026 Davidson Prize at Commodity Classic

Suncrete Announces Support Agreements with a Majority of Warrantholders

PNC Announces Details for First Quarter 2026 Earnings Conference Call, Virtual-Only Annual Shareholders Meeting

ADP National Employment Report: Private Sector Employment Increased by 63,000 Jobs in February; Annual Pay was Up 4.5%

Fuerte Metals Awards Contract for The Coffee Gold Project's Northern Access Route Construction

Abercrombie & Fitch Forecasts Continued Growth as Sales Rise

BigBear.ai Stock Is Down Big, But Smart Money Is Quietly Buying

National Vision (EYE) Surpasses Q4 Earnings and Revenue Estimates

SM ENERGY COMPANY ANNOUNCES CASH TENDER OFFER FOR UP TO $750.0 MILLION AGGREGATE PRINCIPAL AMOUNT OF 8.375% SENIOR NOTES DUE 2028 ORIGINALLY ISSUED BY CIVITAS RESOURCES

Turning Point Brands: 2 Minor Reasons For Major Sell-Off

BASFY Wraps Up OBA Transfer to Catexel, Advances Portfolio Shift

Wix.com (WIX) Q4 Earnings Top Estimates

Edible Garden Selects Tetra Pak® to Power New Midwest Ready-to-Drink Facility at Natural Products Expo West® 2026

Multinational Corporation Valued at Over a Trillion Dollars Expands Its Bond Deployment to Cover Its Mexico Employees

Banking giant upgrades its Tesla stock price target

Vopak delays investment on South African LNG project to 2028

Form 8.3 LondonMetric Property Plc

Price gains for gold, silver as safe-haven demand resumes

FBS Global Highlights Approximately $78.5 Million Secured Project Pipeline Across Public and Commercial Infrastructure

INOVIO and Akeso Announce Clinical Collaboration to Advance Novel Combination Therapy for Glioblastoma (GBM)